Year: 2024
Type: article
Abstract: Neurodegenerative disorders, including traumatic injuries to the central nervous system (CNS) and neurodegenerative diseases, are characterized by early axonal damage, which does not regenerate in the adult mammalian CNS, leading to permanent neurological deficits. One of the primary causes of the loss of regenerative ability is thought to be a developmental decline in neurons' intrinsic capability for axon growth. Different molecules are involved in the developmental loss of the ability for axon regeneration, including many transcription factors. However, the function of microRNAs (miRNAs), which are also modulators of gene expression, in axon re-growth is still unclear. Among the various miRNAs recently identified with roles in the CNS, miR-17, which is highly expressed during early development, emerges as a promising target to promote axon regeneration. Here, we used adeno-associated viral (AAV) vectors to overexpress miR-17 (AAV.miR-17) in primary cortical neurons and evaluate its effects on neurite and axon regeneration in vitro. Although AAV.miR-17 had no significant effect on neurite outgrowth and arborization, it significantly enhances neurite regeneration after scratch lesion and axon regeneration after axotomy of neurons cultured in microfluidic chambers. Target prediction and functional annotation analyses suggest that miR-17 regulates gene expression associated with autophagy and cell metabolism. Our findings suggest that miR-17 promotes regenerative response and thus could mitigate neurodegenerative effects.
DOI: 10.3390/ijms25169057
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,296
Awards: G1726546787, BIOFÁRMACO DE RAAV PARA TERAPIA GÊNICA CONTRA DISTÚRBIOS NEURODEGENERATIVOS BASEADO NA EXPRESSÃO DO MICRORNA MIR-146A, G3714567167, G3814191668, CENTRO DE PRODUÇÃO DE VETORES VIRAIS PARA A TECNOLOGIA DE CRISPR-CAS9: FOCO EM DOENÇAS NEUROLÓGICAS, G4799504954, G6530356893, BIOFÁRMACOS DE RAAV PARA EXPRESSÃO DE PROTEÍNAS TERAPÊUTICAS PARA NEURODEGENERAÇÃO COM BASE EM TERAPIA GÊNICA E CRISPRA, G717670088, ANÁLISE DO PAPEL DE MICRORNAS NA DEGENERAÇÃO E REGENERAÇÃO APÓS LESÃO TRAUMÁTICA NO SISTEMA NERVOSO CENTRAL., G7625554796, G7702023559
OpenAlex ID: W4401895109
